The use of antiplatelet agents in patients with ischemic stroke is recommended. In this study,
we compared the efficacy and safety of the treatment of clopidogrel plus aspirin (ASA) and …

Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Background Stroke is common during the first few weeks after a transient ischemic attack
(TIA) or minor ischemic stroke. Combination therapy with clopidogrel and aspirin may …

Background—The Clopidogrel in High-risk patients with Acute Non-disabling
Cerebrovascular Events (CHANCE) trial showed that the combined treatment of clopidogrel …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

Background The aim of this study was to analyze the benefits and safety associated with the
combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic …

Background: Antiplatelet agents are the mainstay for secondary prevention of non-
cardioembolic stroke. This systematic review examined the safety and efficacy of short …

Objective: Patients experiencing acute ischemic stroke or transient ischemic attack are
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …

Background Patients with transient ischemic attack (TIA) or minor stroke are at risk of
strokes. One of the precautionary measures to reduce risk of stroke in these patients is …

Background and Purpose—The role of aspirin plus clopidogrel (A+ C) therapy compared
with aspirin monotherapy in patients presenting with acute ischemic stroke (IS) or transient …